Putnam BioRevolution ETF REGN Holdings History
Putnam BioRevolution ETF's Regeneron Pharmaceuticals Inc Holding Summary
As of 2025-04-30, Putnam ETF Trust held 286.00 shares of Regeneron Pharmaceuticals Inc(REGN), totaling $171,250.00. This investment constitutes 3.59% of their stock portfolio, and Putnam ETF Trust now holds 0% of the outstanding Regeneron Pharmaceuticals Inc(REGN) stock.
The initial trade took place in 2022Q4. And since then Putnam BioRevolution ETF has made 4 purchases of REGN, at an average price of $743.46, for a total of 329.00 shares. In addition, there have been 2 sales at an average price of $831.90 for 43.00 shares. Based on historical transaction data and REGN's current price of $560.93, Putnam BioRevolution ETF's estimated gain on his REGN holdings is $-48,400.29, reflecting a -19.79% gain to date.
Putnam BioRevolution ETF REGN ($560.93) Holding Chart
Putnam BioRevolution ETF REGN ($560.93) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1